Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance

Diabetes

Volumn 47, Issue 11, 1998, Pages 1757-1762

  Fernández Real, José Manuel ^a   Broch, Montserrat ^b   Ricart, Wifredo ^a   Casamitjana, Roser ^c   Gutierrez, Cristina ^b   Vendrell, Joan ^b   Richart, Cristobal ^b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS INDEX; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; PREMENOPAUSE; RECEPTORS, TUMOR NECROSIS FACTOR; SEX CHARACTERISTICS; SOLUBILITY;

EID: 0031671469     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.11.1757     Document Type: Article

References (40)

1. Beutler B, Cerami A: The biology of cachectin/TNF-α primary mediator of the host response. Ann Rev Immunol 7:625-655, 1989
2. Grunfeld C, Feingold KR: The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3:143-158, 1991
3. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
4. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of rumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
5. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNFα by human muscle: relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
6. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 13:151-153, 1992
7. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962, 1994
8. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM: Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46:451-155, 1997
9. Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725, 1996
10. Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A: Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 42:270-275, 1989
11. Seckinger P, Isaaz S, Dayer J-M: Purification and biologic characterization of a specific tumor necrosis factor a inhibitor. J Biol Chem 264:11966-11973, 1989
12. Engelmann HD, Aderka D, Rubinstein M, Rotman D, Wallach D: A tumor necrosis factor binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264:11974-11980, 1989
13. Engelmann HD, Novick D, Wallach D: Two tumor necrosis factor binding proteins purified from human urine: evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265:1531-1536, 1990
14. Nophar Y, Kemper O, Brakebusch C, Engelmann H, Zwang R, Aderka D, Holtmann H, Wallach D: Soluble forms of tumor necrosis factors (TNF-Rs): the cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 9:3269-3278, 1990
15. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329, 1992
16. Smith RA, Baglioni C: The active form of tumor necrosis factor is a trimer. J Biol Chem 262:6951-6954, 1987
17. Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE, Griveas I, Katsilambros N, Flier JS: Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 82:3408-3413, 1997
18. Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, Richart C, Soler J: The TNF-α Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46:1468-1472, 1997
19. Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Broch M, Vendrell J, Richart C: The TNF-β Nco I polymorphism is not associated with hypertriglyceridemia or insulin resistance in lean and obese subjects. Biochem Biophys Res Commun 236:829-832, 1997
20. Ricart W, Gonzalez-Huix F, Conde V, Grup per 1'Evaluacio de la Composició Corporal de la Població de Catalunya: The evaluation of the state of nutrition through the determination of anthropometric parameters: new tables in the working population in Catalonia (Spain). Med Clin (Barc) 100:681-691, 1993
21. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
22. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 79:790-800, 1987
23. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
24. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
25. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668, 1996
26. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614, 1997
27. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H: Selective upregulation of the 75-kDa tumor necrosis (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 150:4346-4353, 1993
28. Jovinge S, Hamsten A, Tornvall P, Proudler A, Bavenholm P, Ericsson CG, Godsland I, de Faire U, Nilsson J: Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 47:113-118, 1998
29. Torre-Amione G. Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL: Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93:704-711, 1996
30. Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kustai G: Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 51:5602-5607, 1991
31. Hollenbeck C, Reaven GM: Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64:1169-1173, 1987
32. Reaven GM, Hollenbeck CB, Chen Y-DI: Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55, 1989
33. Yki-Järvinen H, Koivisto VA: Effect of body composition on insulin sensitivity. Diabetes 32:965-969, 1983
34. Orchard TJ, Becker DJ, Kuller LH, Wagener D, LaPorte RE, Drash AI: Age and sex variations in glucose tolerance and insulin responses: parallels with cardiovascular risk. J Chron Dis 35:123-132, 1982
35. Yki-Järvinen H: Sex and insulin sensitivity Metabolism 33:1011-1015, 1984
36. Hale PJ, Wright JV, Nattrass M: Differences in insulin sensitivity between normal men and women. Metabolism 34:1133-1138, 1985
37. Paula FJA, Pimenta WP, Saad MJA, Paccola GMGF, Piccinato CD, Foss MC: Sex-related differences in peripheral glucose metabolism in normal subjects. Diabetes Metab Rev 15:234-239, 1990
38. Nuutila P, Knuuti J, Mäki M, Laine H, Ruotsalainen U, Teräs M, Haaparanta M, Solin O, Yki-Järvinen H: Gender and insulin sensitivity in the heart and in skeletal muscles: studies using positron emission tomography. Diabetes 44:31-36, 1995
39. Hayashi T, Wojtaszewski JF, Goodyear LJ: Exercise regulation of glucose transport in skeletal muscle. Am J Physiol 273:E1039-E1051, 1997
40. LeBlanc J, Nadeau A, Richard D, Tremblay A: Variations in plasma glucose, insulin, growth hormone, and catecholamines in response to insulin in trained and non-trained subjects. Metabolism 31:453-456, 1982